Fetal trimethadione syndrome
Fetal Trimethadione Syndrome
Fetal Trimethadione Syndrome (pronunciation: fee-tal try-meth-oh-dye-on sin-drome) is a rare congenital disorder that occurs in infants whose mothers have taken the anticonvulsant drug Trimethadione during pregnancy.
Etymology
The term "Fetal Trimethadione Syndrome" is derived from the drug Trimethadione, which is known to cause the syndrome, and the word "fetal", referring to the unborn offspring in the stage of development.
Symptoms
The syndrome is characterized by a variety of physical abnormalities and developmental delays. These may include craniofacial abnormalities, cardiac defects, growth retardation, and intellectual disability.
Causes
The primary cause of Fetal Trimethadione Syndrome is the maternal use of the anticonvulsant drug Trimethadione during pregnancy. This drug crosses the placenta and can affect the developing fetus.
Diagnosis
Diagnosis of Fetal Trimethadione Syndrome is typically made based on a thorough clinical evaluation, a detailed patient history, and specialized tests such as ultrasound and genetic testing.
Treatment
Treatment of Fetal Trimethadione Syndrome is symptomatic and supportive. This may include surgical intervention for physical abnormalities, special education for intellectual disability, and other therapies as needed.
Related Terms
- Congenital disorder
- Trimethadione
- Craniofacial abnormalities
- Cardiac defects
- Growth retardation
- Intellectual disability
- Placenta
- Ultrasound
- Genetic testing
External links
- Medical encyclopedia article on Fetal trimethadione syndrome
- Wikipedia's article - Fetal trimethadione syndrome
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski